Mohana Krishna Gopinath
About Mohana Krishna Gopinath
Data last updated:
Mohana Krishna Gopinath is a Director at Slava Therapeutics Private Limited (since 2020) and Director at Antler Life Sciences Private Limited (since 2019). The companies operate in Pharma and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹16.22 Cr; the largest is Slava Therapeutics Private Limited at ₹12.14 Cr (FY 2020). Earlier, Mohana Krishna Gopinath was a Director at Met Therapeutics Private Limited (2014–2016) and Director at Bioviz Technologies Private Limited (2009–2016).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Slava Therapeutics Private Limited U24304TG2017PTC118116 | Director | 13 Nov 2020 | 2017 | ₹12.14 Cr (FY 2020) | Active |
 Antler Life Sciences Private Limited U24239TG2019PTC130087 | Director | 28 Jan 2019 | 2019 | ₹4.08 Cr (FY 2020) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Met Therapeutics Private Limited U24100TG2014PTC092717 | Director | 03 Feb 2014 | 2014 | Active | |
 Bioviz Technologies Private Limited U72300TG2007PTC053795 | Director | 19 Feb 2009 | 2007 | ₹76.3 Lakh (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mohana Krishna Gopinath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sirisha Pilla | 07816397 | Slava Therapeutics Private Limited , Antler Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohana Krishna Gopinath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohana Krishna Gopinath
Mohana Krishna Gopinath currently holds 2 directorships: Slava Therapeutics Private Limited (Director, since 13 Nov 2020, revenue ₹12.14 Cr (FY 2020)); Antler Life Sciences Private Limited (Director, since 28 Jan 2019, revenue ₹4.08 Cr (FY 2020)).
Mohana Krishna Gopinath was first appointed on 19 Feb 2009 as Director at Bioviz Technologies Private Limited. The most recent appointment on record is 13 Nov 2020 at Slava Therapeutics Private Limited.
The 2 current companies of Mohana Krishna Gopinath that report revenue have a combined latest revenue of ₹16.22 Cr: Slava Therapeutics Private Limited ₹12.14 Cr (FY 2020); Antler Life Sciences Private Limited ₹4.08 Cr (FY 2020).
Mohana Krishna Gopinath held 2 earlier board appointments: Met Therapeutics Private Limited (Director, 03 Feb 2014 to 14 Jul 2016); Bioviz Technologies Private Limited (Director, 19 Feb 2009 to 14 Jul 2016).
The current boards of Mohana Krishna Gopinath's companies include Sirisha Pilla (Slava Therapeutics Private Limited).